HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Nicolas Hunzelmann Selected Research

Nicolas Hunzelmann Research Topics

Disease

6	Pemphigus (Pemphigus Vulgaris) 03/2010 - 01/2002
4	Hypersensitivity (Allergy) 10/2005 - 02/2004
3	Autoimmune Diseases (Autoimmune Disease) 02/2007 - 03/2005
3	Melanoma (Melanoma, Malignant) 06/2006 - 09/2003
2	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 03/2010 - 05/2008
2	Sclerosis 01/2009 - 11/2007
2	Systemic Scleroderma (Systemic Sclerosis) 01/2009 - 05/2008
2	Bullous Pemphigoid (Pemphigoid) 12/2007 - 03/2003
2	Neoplasms (Cancer) 06/2006 - 09/2003
2	Granuloma 02/2005 - 02/2004
1	Localized Scleroderma (Morphea) 09/2009
1	Fever (Fevers) 05/2008
1	Myositis (Idiopathic Inflammatory Myopathies) 05/2008
1	Drug Eruptions (Drug Eruption) 01/2008
1	Blister (Bulla) 12/2007
1	Raynaud Disease (Raynaud's Disease) 11/2007
1	Neoplasm Metastasis (Metastasis) 06/2006
1	Photosensitivity Disorders (Photodermatitis) 09/2005
1	Infection 07/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2005
1	Connective Tissue Diseases (Connective Tissue Disease) 03/2005
1	Foreign-Body Reaction 02/2005
1	Calcinosis 02/2004
1	Kidney Failure (Renal Failure) 02/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2004
1	Panniculitis 01/2004
1	Thyroid Diseases (Thyroid Disease) 11/2002
1	Acanthosis Nigricans 05/2002
1	Tetanus 01/2002
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 01/2002

Drug/Important Bio-Agent (IBA)

7	AutoantibodiesIBA 03/2010 - 03/2003
5	Immunoglobulin G (IgG)IBA 03/2010 - 11/2002
3	rituximab (Mabthera)FDA Link 05/2008 - 07/2005
3	mycophenolate mofetil (Cellcept)FDA LinkGeneric 12/2007 - 09/2005
2	Desmoglein 3IBA 03/2010 - 08/2006
2	PlasticsIBA 05/2008 - 06/2006
2	AntibodiesIBA 05/2008 - 01/2002
2	Azathioprine (Imuran)FDA LinkGeneric 12/2007 - 11/2006
2	Methylprednisolone FDA LinkGeneric 12/2007 - 11/2006
2	SodiumIBA 12/2007 - 11/2006
2	EpitopesIBA 08/2006 - 03/2003
2	Cysteine Proteases (Cysteine Protease)IBA 06/2006 - 09/2003
2	Peptide Hydrolases (Proteases)IBA 06/2006 - 09/2003
2	VenomsIBA 10/2005 - 01/2004
2	AntigensIBA 03/2003 - 01/2002
1	Immunoglobulin E (IgE)IBA 03/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2008
1	Antinuclear AntibodiesIBA 11/2007
1	Glutens (Glutelin)IBA 02/2007
1	DesmogleinsIBA 08/2006
1	CollagenIBA 06/2006
1	Cathepsin BIBA 06/2006
1	CathepsinsIBA 06/2006
1	Fibrillar CollagensIBA 06/2006
1	Collagen Type I (Type I Collagen)IBA 06/2006
1	Cystatin AIBA 06/2006
1	Cystatin BIBA 06/2006
1	tamsulosin (Flomax)FDA Link 10/2005
1	Histidine-tRNA LigaseIBA 03/2005
1	LigasesIBA 03/2005
1	SiliconesIBA 02/2005
1	Minocycline (Cyclops)FDA LinkGeneric 02/2005
1	NickelIBA 02/2004
1	PalladiumIBA 02/2004
1	Heparin (Liquaemin)FDA LinkGeneric 02/2004
1	PhosphorusIBA 02/2004
1	PlatinumIBA 02/2004
1	CalciumIBA 02/2004
1	Nadroparin (Nadroparin Calcium)IBA 02/2004
1	EnzymesIBA 09/2003
1	leupeptinIBA 09/2003
1	E 64IBA 09/2003
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2003
1	Cysteine Proteinase InhibitorsIBA 09/2003
1	GelatinasesIBA 09/2003
1	GelatinIBA 09/2003
1	collagen type XVII (collagen XVII)IBA 03/2003
1	Iodide Peroxidase (Deiodinase)IBA 11/2002
1	Epidermal Growth Factor Receptor (EGF Receptor)IBA 05/2002
1	TNFR-Fc fusion protein (etanercept)FDA Link 01/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002

Therapy/Procedure

3	Immunotherapy 10/2005 - 01/2004
1	Phototherapy (Light Therapy) 09/2009
1	Drug Therapy (Chemotherapy) 07/2005
1	Subcutaneous Injections 02/2004
1	Body Piercing (Piercing, Body) 02/2004
1	Injections 02/2004
1	Microspheres (Microsphere) 03/2003